Bone Marrow Transplantation and Immune Deficiency

Publications

Alexander, JL; Dávila Saldaña, BJ; Brazauskas, R; Dammalapati, SG; Griffith, LM; Shah, AJ; Shimano, KA; Ochs, HD; Bleesing, JJ; Ebens, CL; Cowan, MJ; Petrovic, A; Pai, S-Y; Burroughs, LM. Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report. Blood advances. 2026; 10(5):1783-1798.

Alkhouli, L; Badia, P; Bakinowski, E; Craddock, J; Culbertson, C; Dandoy, CE; Davies, SM; Desalvo, AM; Gorfinkel, L; Huber, J; Patel, V; Jodele, S; Wall, S; Epling, P. Toward Standardized Screening for Chronic GVHD: Insights from the Engraft Learning Network. Transplantation and Cellular Therapy. 2026; 32(2):s252-s253.

Arnold, DE; Kaviany, S; Aluri, J; Calvo, KR; Mehta, SS; Tobin, JM; Schuettpelz, LG; Saucier, N; Schmitz, EG; Murguía-Favela, L; Pai, S-Y; Bednarski, JJ; Connelly, JA; Cooper, MA. Clinical characteristics, management, and hematopoietic cell transplantation of patients with TLR8 gain-of-function. Blood advances. 2026; 10(6):1967-1976.

Arnold, DE; Leiding, JW; Logan, B; Marsh, RA; Griffith, LM; Grunebaum, E; Murguía-Favela, L; Mallhi, K; Chellapandian, D; Deal, CL; Torgerson, T; Malech, HL; Kang, EM; Parikh, S. Umbilical Cord Blood Transplantation Provides an Alternative for Patients With Chronic Granulomatous Disease Lacking HLA-Matched Donors: A PIDTC Report. Transplantation and Cellular Therapy. 2026; 32(1):89.e1-89.e10.

Ashraf, A; Murphey, C; Sper, C; Webster, A; Lane, A; Mesa, S; Garcia, F; Perez, R; Chamblin, C; Davies, SM; Khandelwal, P. Underlying Diagnosis and RBC Transfusions Increase HLA Antibodies in Children before Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 2026; 32(2):118.e1-118.e4.

Borogovac, A; Efebera, Y; Clark, L; Houk, A; Ragon, BK; Hamilton, BK; Devine, SM; Dandoy, CE; Plasteras, J; Wall, S; Horowitz, MM; Khera, N; Juckett, MB; Bhatt, N. Clinical Decision-Making in Hematopoietic Cell Transplantation (HCT) for Severe Aplastic Anemia (SAA): Insights from a National Survey of Physicians. Transplantation and Cellular Therapy. 2026; 32(2):s318-s319.

Bota, KE; Young, K; Wall, J; Koo, J; Myers, K; Ramos, KN; Dandoy, CE; Davies, SM; Taggart, CB. Got Nutrition? Exclusion of Nutrition Intervention at Key Points during Hematopoietic Stem Cell Transplantation Negatively Impacts Frailty. Transplantation and Cellular Therapy. 2026; 32(2):s607-s608.

Brumm, VL; Kidd, SA; Logan, BR; Chunara, F; Heimall, J; Griffith, LM; Kohn, DB; Sanchez, L; Bednarski, JJ; Martinez, C; Pulsipher, MA; Puck, JM; Cowan, MJ; Shah, AJ. Neurodevelopmental outcomes following hematopoietic cell transplantation for patients with severe combined immunodeficiency (SCID): A PIDTC study. Journal of Human Immunity. 2026; 2(1):e20250163.

Chandra, S; Greis, KD; Chutipongtanate, S; Luebbering, N; Webster, A; Poisson, KE; Fisher, KS; Smiley, K; Marsh, RA; Jordan, MB; Davies, SM. Novel CSF biomarkers for facilitating diagnosis of CNS-HLH from other neuroinflammatory disorders. Blood advances. 2026; 10(4):960-972.

Chandra, S; Greis, KD; Chutipongtanate, S; Luebbering, N; Webster, A; Poisson, KE; Fisher, KS; Smiley, K; Marsh, RA; Jordan, MB; Davies, SM. Novel CSF biomarkers for facilitating diagnosis of CNS-HLH from other neuroinflammatory disorders. Blood advances. 2026; 10(4):960-972.

Chandrakasan, S; Westbrook, A; Griffith, LM; Hagin, D; Iyengar, S; Mangurian, C; Scalchunes, C; Sullivan, KE; Zablocki, A; Bakshi, N; Torgerson, T; Cowan, MJ; Ochs, HD; Parikh, S. Clinical spectrum of Wiskott-Aldrich syndrome carriers: Self-reported survey of 193 carriers. Clinical Immunology. 2026; 283:110658.

Cook, E; Rotz, SJ; Auletta, JJ; Bidgoli, A; Blacken, R; Johnson, D; Badia, P; French, K; Hartley, DM; Kent, GR; Schoettler, ML; Sampson, M; Dandoy, CE; Fitch, TJ. Central Venous Catheter Removal After Hematopoietic Stem Cell Transplant: A Review and Perspective. Pediatric Blood and Cancer. 2026; 73(3):e70001.

Ellifson, GK; Dandoy, CE; Fabrizio, VA; Kapadia, M; Lehmann, LE; Olson, KE; Puranik, CP; Treister, N; Thikkurissy, S; Chin, K. Assessment of Oral Health Practices for Patients Receiving Stem Cell Transplantation at Pediatric Oncology Centers. Transplantation and Cellular Therapy. 2026; 32(2):s315-s316.

Ghalehsari, N; Pandey, M; Auletta, JJ; Beaver, E; Davies, SM; Espinoza-Gutarra, MR; Fraint, E; Holter-Chakrabarty, J; Howard, D; Knutson, J; Ramos, KN; Shah, R; Hall, AG; Gomez-Arteaga, A. Physician Advocacy for Hematopoietic Cell Transplantation and Cell Therapy: Overcoming Challenges to Reduce Disparities and Improve Outcomes for Patients. Transplantation and Cellular Therapy. 2026; 32(1):12.e1-12.e4.

Gibson, NM; Nguyen, NTD; Amaral, S; Hsu, J; Haney, M; Heimbruch, KE; Sabulski, A; Zurawel, AA; Davidow, KA; Lind, KT; Hall, L; Bailey, C; Olson, TS; Kwiatkowski, JL. Impact of Iron Overload on Hematopoietic Stem Cell Transplant in Children with Non-Malignant Hematological Disorders. Blood advances. 2026.

Guilcher, GMT; Dalal, S; Suresh, T; Yelamali, AR; Arora, J; Aljayyousi, H; Bhatia, M; Haight, AE; Khandelwal, P; Khoury, R; Shah, NC; Stenger, EO; Yelamanchili, N; Shenoy, S. Long-term Follow-up After Mixed Donor Myeloid Chimerism at 1 Year Post Transplantation for Sickle Cell Disease. Transplantation and Cellular Therapy. 2026.

Hudda, Z; Webster, A; Anderson, E; Badia, P; Bagatell, R; Bhar, S; Bidgoli, A; Boyd, K; Chaudhury, S; Cisneros, GS; Weiss, BD; Yazdani, S; Zheng, D; Dandoy, CE. Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter Study. Transplantation and Cellular Therapy. 2026; 32(2):199.e1-199.e12.

Ibrahimova, A; Luebbering, N; Strecker, L; Langenberg, L; Abdullah, S; Lake, KE; Wilhelm, J; Lane, A; Gloude, N; Myers, K; Dandoy, C; Towe, C; Khandelwal, P; Jodele, S; Davies, SM. Neutrophil extracellular traps, endothelial injury and use of abatacept for graft versus host disease prophylaxis. Haematologica. 2026.

Ibrahimova, A; Bidgoli, A; Ashraf, A; Krogman, A; Klink, G; Teusink-Cross, A; Schoettler, ML; Davies, SM; Khandelwal, P. Real world experience using belumosudil for treatment of chronic graft versus host disease in children and young adults. Bone Marrow Transplantation. 2026.

Jodele, S. Targeting the lectin pathway in TA-TMA. Blood advances. 2026; 10(1):181-182.

Kapadia, M; Nishitani, M; Alkhouli, L; Badia, P; Blacken, R; Cook, E; Culbertson, C; Dandoy, CE; Daraiseh, N; Davies, SM; Staton, S; Stuckey, R; Young, K; Craddock, J. A Multicenter Quality Improvement Initiative to Reduce Central Venous Catheter Line Days after Transplant Cellular Therapy across the Engraft Learning Health Network. Transplantation and Cellular Therapy. 2026; 32(2):s360-s361.

Koo, J; Miller, E; O'conner, A; Myers, KC; Mehta, PA; Davies, SM. Radiation-Free Reduced-Intensity Conditioning Achieves Excellent Outcomes in Pediatric Severe Aplastic Anemia. Transplantation and Cellular Therapy. 2026; 32(2):s581.

Koo, J; Langenberg, L; Walter, E; Zhao, X; Setchell, K; Lake, KE; Khandelwal, P; Lane, A; Manjrekar, P; Myers, KC; Reynaud, D; Sabulski, A; Teusink-Cross, A; Jodele, S; Davies, SM. Lower Isn't Better: Baseline LDL-C Identifies Endothelial Vulnerability and Outcomes after HSCT. Transplantation and Cellular Therapy. 2026; 32(2):s594.

Koo, J; Schwarz, D; Haney, M; Putra, J; Kim, J; Cheng, L; Korn, E; Steltz, SK; Schwarz, L; Loveless, SK; Myers, KC; Shimamura, A; Grover, AS; Wehrman, A. Liver Disease in Shwachman Diamond Syndrome: Implications for Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 2026; 32(2):s328-s329.

Lawhorn, E; Mani, B; Howell, JC; Davies, SM; Myers, K; Hudda, Z. Longitudinal Outcomes of Reproductive Function in Male Pediatric Hematopoietic Stem Cell Transplant Survivors. Transplantation and Cellular Therapy. 2026; 32(2):s356.

Maier, ST; Dandoy, CE; Davies, SM; Gorfinkel, L; Huber, J; Jodele, S; Kapadia, M; Kent, G; Lehmann, LE; Myers, K; Nguyen, A; Nishitani, M; Parker, L; Epling, P. Activating Epic’s Flowsheet for Standardized Chronic GVHD Assessment: A Multi-Center Implementation Framework to Enable Standardized Documentation. Transplantation and Cellular Therapy. 2026; 32(2):s520-s521.

Marsh, RA; Cowan, MJ. The evolving landscape of primary hemophagocytic lymphohistiocytosis: Long-term outcomes following hematopoietic cell transplantation. Journal of Allergy and Clinical Immunology. 2026; 157(2):340-341.

Mccormack-Spivey, S; Sabulski, A; Lane, A; Davies, SM; Chandra, S. Defining and Characterizing Poor Graft Function after Allogeneic HSCT in Children and Young Adults: Risk Factors and Impact on Survival. Transplantation and Cellular Therapy. 2026; 32(2):s585.

Munshi, PN; Yuen, C; Al-Juhaishi, T; Jensen, E; Nemecek, ER; Sandmaier, B; Davies, SM; Auletta, JJ; Chakrabarty, JH. Breaking Access Barriers to Autologous Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy in Hematologic Malignancies-an ASTCT-NMDP ACCESS Initiative. Transplantation and Cellular Therapy. 2026.

Obermark, T; Debnath, P; Ayyala, RS; Danziger-Isakov, LA; Koo, J; Myers, KC; Otto, WR; Tanimoto, A; Trout, AT; Morin, CE. Utility of Computed Tomography Surveillance of Asymptomatic Infection in Children and Young Adults Before Allogeneic Hematopoietic Stem Cell Transplant. Pediatric Blood and Cancer. 2026; e70175.

Paisley, A; Foster, K; Gover, I; Diebold, S; Lane, A; Hardie, W; Ruff, K; Burg, G; Towe, C; Khandelwal, P; Koo, J; Davies, SM; Myers, K. Pediatric Pulmonary Rehabilitation after Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 2026; 32(2):s63.

Ramos, KN; Langenberg, L; Lake, KE; Hoerth, C; Luebbering, N; Haslam, D; Newburg, D; Morrow, AL; Ollberding, NJ; Teusink, A; Watanabe-Chailland, M; Romick-Rosendale, L; Davies, SM; Khandelwal, P. 2’-Fucosyllactose (Human Milk Oligosaccharide) Reduces Dysbiosis and Acute GI GVHD in Children and Young Adults Following HSCT: A Prospective, Single-Center Phase II Study. Transplantation and Cellular Therapy. 2026; 32(2):s570.

Rayes, A; Logan, BR; Liu, X; Dara, J; Buckley, RH; Oved, JH; Kapoor, N; Kapadia, M; Chandra, S; Martinez, CA; Heimall, J; Haddad, E; Pai, S-Y; Dvorak, CC. Outcomes following matched sibling donor transplantation for severe combined immunodeficiency: a report from the PIDTC. Blood advances. 2026; 10(3):887-900.

Strecker, L; Abts, MF; Baker, KS; Freedman, JL; Doherty, EE; Eissa, H; Gaffin, JM; Goldfarb, SB; Houin, P; Josephson, MB; Young, LR; Zinter, MS; Davies, SM; Ibrahimova, A. MCP-1 in Broncho-Alveolar Fluid and Plasma in Children with Lung Injury after Hematopoietic Stem Cell Transplant: A Transpire Study. Transplantation and Cellular Therapy. 2026; 32(2):s581-s582.

Strecker, L; Mishra, AK; Abts, MF; Freedman, JL; Baker, S; Doherty, EE; Eissa, H; Gaffin, JM; Goldfarb, SB; Houin, P; Young, LR; Zinter, MS; Davies, SM; Ibrahimova, A. “to Bronch or Not to Bronch? - Biologic Markers of Lung Injury in the Bronchoalveolar Lavage Fluid of Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation, a Transpire Study. Transplantation and Cellular Therapy. 2026; 32(2):s584-s585.

Taylor, AO; Hong, S; Jones, S; Ng, K; Gooley, TA; Bhatt, N; Hellewell, EM; Sung, AD; Ahmed, N; Morey, C; Yingling, S; Edgar, CM; Browning, AL; Lee, CJ. Relationship between Social Drivers of Health and Clinician Adherence to Late Effects Screening Among Allogeneic HCT Survivors in the United States. Transplantation and Cellular Therapy. 2026; 32(2):s24-s25.

Vichare, V; Kilich, G; Cunningham-Rundles, C; Onyekaba, M; Abraham, RS; Puck, J; Fuleihan, R; Marsh, RA; Sullivan, KE. Automated data extraction model for the USIDNET registry: Bigger, faster, and better data collection. Journal of Human Immunity. 2026; 2(1):e20250118.

Zoref-Lorenz, A; Allen, CE; Behrens, EM; Chandrakasan, S; Chien, M; Hermiston, ML; Hinson, AP; Intzes, S; Isakoff, MS; Leiding, JW; Modica, R; Riskalla, M; Baker, A; Ward, B. Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: the REAL-HLH study. Blood advances. 2026; 10(5):1564-1575.